Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Idorsia (0RQE)

Idorsia Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RQE
DateTimeSourceHeadlineSymbolCompany
12/02/202522:00UK RegulatoryIdorsia publishes the resolutions for the upcoming bondholder meetingLSE:0RQEIdorsia Ltd
15/01/202522:45UK RegulatoryIdorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholdersLSE:0RQEIdorsia Ltd
14/01/202506:00UK RegulatoryIdorsia publishes an invitation to a bondholder meetingLSE:0RQEIdorsia Ltd
13/01/202506:00UK RegulatoryIdorsia to call for a bondholder meetingLSE:0RQEIdorsia Ltd
20/12/202406:00UK RegulatoryIdorsia provides update on the exclusive negotiations for the global rights to aprocitentanLSE:0RQEIdorsia Ltd
27/11/202406:00UK RegulatoryIdorsia enters into exclusive negotiations for global rights to aprocitentanLSE:0RQEIdorsia Ltd
11/11/202416:45UK RegulatoryIdorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific SessionsLSE:0RQEIdorsia Ltd
29/10/202406:00UK RegulatoryIdorsia announces financial results for the first nine months of 2024LSE:0RQEIdorsia Ltd
16/10/202405:00UK RegulatoryNew data on aprocitentan to be presented at the ASN Kidney Week 2024LSE:0RQEIdorsia Ltd
17/09/202415:45UK RegulatoryIdorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024LSE:0RQEIdorsia Ltd
05/09/202415:45UK RegulatoryNew data on aprocitentan to be presented at the AHA Hypertension Scientific Sessions 2024LSE:0RQEIdorsia Ltd
02/09/202415:45UK RegulatoryAmended terms of Idorsia’s 2024 convertible bonds become effectiveLSE:0RQEIdorsia Ltd
25/07/202405:00UK RegulatoryIdorsia announces financial results for the first half 2024LSE:0RQEIdorsia Ltd
18/07/202415:45UK RegulatoryInvitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
01/07/202405:00UK RegulatoryIdorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
28/06/202415:45UK RegulatoryHigher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
25/06/202415:45UK RegulatoryHigher cantonal composition authority approved the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
21/06/202405:00UK RegulatoryIdorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’ categoryLSE:0RQEIdorsia Ltd
13/06/202409:00UK RegulatoryIdorsia holds its Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
03/06/202405:00UK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
03/06/202405:00UK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
31/05/202405:00UK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
31/05/202405:00UK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
23/05/202405:00UK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
23/05/202405:00UK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
21/05/202405:00UK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
21/05/202405:00UK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
21/05/202404:50UK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
21/05/202404:50UK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
21/05/202404:40UK RegulatoryIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueLSE:0RQEIdorsia Ltd
 Showing the most relevant articles for your search:LSE:0RQE